Furthermore, it will also be crucial to establish if the TPα/TPβ-PRK1/PRK2 signalling axis plays a role in tumour progression in other carcinomas where both the TP and the PRKs are implicated including in breast and bladder cancer [42, 59]. The gene discussed is PKN2; the disease is urinary bladder cancer.